Figure 1. Patient flow diagram.
| World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc |
| Journal website https://www.wjnu.org |
Original Article
Volume 000, Number 000, November 2023, pages 000-000
Clinical Utiliy of Routine Postoperative Laboratory Tests After Laparoscopic Prostate Surgery
Figure
Tables
| Total (n = 231) | Radical prostatectomy (n = 156) | Simple prostatectomy (n = 75) | |
|---|---|---|---|
| ASA: American Society of Anesthesiology; BMI: body mass index; IQR: interquartile range; SD: standard deviation. | |||
| Age, years, mean (SD) | 65.68 (7.03) | 64.35 (6.52) | 68.44 (7.28) |
| BMI, kg/m2, mean (SD) | 27.09 (3.96) | 27.17 (3.81) | 26.89 (4.29) |
| Length of surgery, min, mean (SD) | 149.34 (39.39) | 155.71 (37.52) | 136.1 (40.11) |
| Hospital stay, days, median (IQR) | 3 (3.5 - 4.5) | 3 (3 - 4) | 4 (3 - 5) |
| ASA (%) | |||
| I | 12 (5.2) | 8 (5.2) | 4 (5.3) |
| II | 174 (75.7) | 125 (80.6) | 49 (65.3) |
| III | 41 (17.8) | 23 (14.2) | 19 (25.3) |
| IV | 3 (1.3) | - | 3 (4) |
| Antiplatelet or anticoagulant (%) | 46 (19.9) | 24 (15.4) | 22 (29.3) |
| Pre-operative hemoglobin, g/dL, mean (SD), | 14.67 (1.52) | 14.80 (1.38) | 14.42 (1.75) |
| Pre-operative creatinine, mg/dL, median (IQR) | 0.9 (0.82 - 1.03) | 0.88 (0.80 - 0.99) | 0.98 (0.86 - 1.12) |
| Pre-operative sodium, median (IQR) | 142 (140 - 143) | 141 (141 - 143) | 141.5 (140 - 143) |
| Pre-operative potassium, mean (SD) | 4.53 (0.44) | 4.56 (0.44) | 4.48 (0.45) |
| Pre-operative chloride, mean (SD) | 100.65 (5.26) | 100 (4.90) | 101.34 (6) |
| Prostate volume, mL, median (IQR) | 57 (35 - 100) | 40 (30 - 56) | 111 (95.65 - 130) |
| Intra-operative estimated blood loss, mL, median (IQR) | 200 (100 - 300) | 200 (100 - 300) | 150 (100 - 200) |
| Signs of hemodynamic instability (%) | 72 (31.2) | 46 (29.5) | 26 (34.7) |
| Drain output, mL, median (IQR) | 75 (30 - 140) | 100 (50 - 150) | 50 (23 - 90) |
| Clinically significant blood loss (%) | 11 (4.8) | 4 (1.7) | 7 (3) |
| Blood transfusion (%) | 4 (1.8) | 1 (0.6) | 3 (4) |
| Clavien-Dindo 3+ | 5 (2.1) | 3 (1.9) | 2 (2.6) |
| Clinically significant blood loss | Abnormal laboratory results on day 1 | |||
|---|---|---|---|---|
| Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
| *ASA scores were grouped, as analysis per four categories was colinear with the outcome. ASA: American Society of Anesthesiology; BMI: body mass index; CI: confidence interval. | ||||
| BMI | 0.92 (0.77 - 1.09) | 0.33 | 1.05 (0.97 - 1.14) | 0.26 |
| Simple prostatectomy | 3.93 (1.11 - 13.87) | 0.03 | 2.69 (1.38 - 5.25) | 0.004 |
| ASA 3/4* | 2.46 (0.68 - 8.8) | 0.165 | 3.09 (1.49 - 6.45) | 0.002 |
| Antiplatelet or anticoagulant therapy | 1.53 (0.39 - 6.02) | 0.54 | 2.17 (1.04 - 4.54) | 0.04 |
| Prostate volume | 1.00 (0.99 - 1.02) | 0.29 | 1.00 (0.99 - 1.01) | 0.07 |
| Intraoperative blood loss | 1.003 (1.00 - 1.005) | 0.021 | 1.00 (0.99 - 1.00) | 0.97 |
| Duration of surgery | 1.006 (0.99 - 1.02) | 0.45 | 1.00 (0.99 - 1.01) | 0.71 |
| Signs of hemodynamic instability | 4.19 (1.18 - 14.79) | 0.026 | 0.87 (0.43 - 1.79) | 0.71 |
| Drain output | 1.00 (0.99 - 1.01) | 0.11 | 1.00 (0.99 - 1.00) | 0.20 |
| Odds ratio (95% CI) | P value | |
|---|---|---|
| *ASA scores were grouped, as analysis per four categories was colinear with the outcome. ASA: American Society of Anesthesiology; CI: confidence interval. | ||
| Clinically significant blood loss | ||
| Simple prostatectomy | 3.64 (0.99 - 13.34) | 0.052 |
| Intraoperative blood loss | 1.00 (1.000 - 1.005) | 0.041 |
| Signs of hemodynamic instability | 4.14 (1.12 - 15.35) | 0.034 |
| Abnormal laboratory results on day 1 | ||
| ASA 3/4* | 2.40 (1.10 - 5.24) | 0.029 |
| Simple prostatectomy | 2.25 (1.13 - 4.48) | 0.022 |
| Antiplatelet or anticoagulant therapy | 1.47 (0.66 - 3.27) | 0.350 |